Rotational Stability, Refractive Predictability And Patient Reported Outcomes With Bilateral Clareon Monofocal Toric Iol Implantation

The Clareon monofocal toric intraocular lens (IOL) is a recently released device from Alcon. It is an IOL based on the successful Acrysof format with modifications made to the material and structure aimed at improving optical clarity, rotational stability, and optical side effects. There is a growing demand for prospective data on visual outcomes, rotational stability and patient reported outcome measurements with new devices such as the Clareon toric IOL.  The aim of this study is to prospectively assess the latest Clareon monofocal toric IOL from Alcon in terms of rotational stability, refractive predictability, visual outcomes and to report quality of life. 

Private practice in Adelaide, Australia.

This is a prospective, single surgeon, single site study. The study will recruit 60 eyes of 30 patients undergoing bilateral uncomplicated cataract surgery implanted with Clareon monofocal toric IOLs aimed at emmetropia. Post-operative imaging will be used to assess rotational stability and at three months post-op refractive outcomes will be assessed as well as reporting quality of life utilising the CatProm 5 following bilateral Clareon Toric IOL implantation at 3 months post implantation. 

Study results are currently pending and will be completed at the time of the meeting.

Conclusions will be made at the time of the meeting.